Market revenue in 2023 | USD 2,992.7 million |
Market revenue in 2030 | USD 4,927.2 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Latin America formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is one of the fastest growing regions in the formulation development outsourcing market following Asia Pacific, owing to cost-effectiveness, increase in the number of clinical trials, rising research & development activities, increasing number of drug development outsourcing services, and rise in the number of new entrants venturing into the pharmaceutical market within the region.
Brazil, Mexico, Argentina, Colombia, and Chile are contributing significant shares to the market in Latin America. The market is expected to showcase rapid growth during the forecast period owing to an increase in the number of biopharmaceutical companies expanding their drug development units into this region, which is anticipated to drive the demand for drug formulation development outsourcing activities.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America formulation development outsourcing market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account